Australia to trial ‘backup’ COVID-19 vaccines that can be modified to fight virus mutations – ABC News

Researchers behind a clinical trial of two COVID-19 vaccines in Australia say they will be able to modify the vaccinations if mutations of the virus occur.
Key points:

• Researchers say the mRNA-based vaccine and recombinant protein vaccine being trialled are more targeted
• The Doherty Institute’s Terry Nolan says it is vital Australia has its own vaccine to prevent supply chain issues
• The trials have been expedited to mid-2021 with Federal Government funding

Close to $1.6 million of Federal Government…

Click here to view the original article.